Radioresistance remains a major clinical challenge in
cervical cancer therapy. However, the mechanism for the development of radioresistance in
cervical cancer is unclear. Herein, we determined that growth arrest and DNA-damage-inducible
protein 45α (GADD45α) is decreased in radioresistant
cervical cancer compared to radiosensitive
cancer both in vitro and in vivo. In addition, silencing GADD45α prevents
cervical cancer cells from undergoing radiation-induced DNA damage, cell cycle arrest, and apoptosis. More importantly, our data show that the overexpression of GADD45α significantly enhances the radiosensitivity of radioresistant
cervical cancer cells. These data show that GADD45α decreases the cytoplasmic distribution of APE1, thereby enhancing the radiosensitivity of
cervical cancer cells. Furthermore, we show that GADD45α inhibits the production of
nitric oxide (NO), a nuclear APE1 export stimulator, by suppressing both endothelial
NO synthase (eNOS) and inducible
NO synthase (iNOS) in
cervical cancer cells. In conclusion, our findings suggest that decreased GADD45α expression significantly contributes to the development of radioresistance and that ectopic expression of GADD45α sensitizes
cervical cancer cells to
radiotherapy. GADD45α inhibits the NO-regulated cytoplasmic localization of APE1 through inhibiting eNOS and iNOS, thereby enhancing the radiosensitivity of
cervical cancer cells.